当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 资产负债表

和邦生物

(603077)

  

流通市值:178.40亿  总市值:178.40亿
流通股本:88.32亿   总股本:88.32亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金7,477,303,340.227,244,794,642.396,815,968,668.46,698,975,052.48
  应收票据及应收账款729,827,450.22647,309,732.72810,097,041.48624,267,253.5
        应收账款729,827,450.22647,309,732.72810,097,041.48624,267,253.5
  应收款项融资807,384,161.68575,004,443.3175,708,957.59350,670,396.62
  预付款项175,026,390.07200,860,748.64185,844,965.18187,681,715.12
  其他应收款合计29,364,338.6726,975,498.8539,406,764.5924,074,447.21
  存货4,097,837,252.834,305,105,848.494,210,719,625.73,909,353,584.58
  合同资产22,280,711.6728,679,655.741,262,205.5435,414,590.14
  其他流动资产94,646,789.35115,525,534.8190,898,285.55193,941,479.66
  流动资产合计13,433,670,434.7113,144,256,104.8912,469,906,514.0312,024,378,519.31
非流动资产:
  长期应收款114,842,048.17111,427,740.15111,598,407.95111,773,306.36
  长期股权投资72,413,435.49120,145,357.48121,906,146.96124,638,872.38
  其他权益工具投资316,579,288.95307,750,667.78298,140,966.33302,439,475.6
  其他非流动金融资产465,278,185.83465,278,185.83465,278,185.83465,278,185.83
  固定资产6,128,076,873.786,263,574,576.766,378,566,019.327,368,526,645.82
  在建工程3,493,386,249.193,251,098,731.523,024,300,9852,136,028,735.44
  使用权资产25,521,449.2328,646,614.0632,935,823.9436,268,281.23
  无形资产2,804,432,238.112,816,930,493.792,837,075,383.362,849,903,551.03
  开发支出365,182,508.3341,161,075.48286,544,074.65231,550,023.02
  商誉1,778,155,078.581,778,155,078.581,778,155,078.581,778,155,078.58
  长期待摊费用1,128,301.951,226,415.15-833,962.31
  递延所得税资产135,847,843.52137,647,333.71133,930,341.17145,900,684.07
  其他非流动资产1,309,426,938.85873,371,717.84780,981,640.08633,768,316.51
  非流动资产合计17,010,270,439.9516,496,413,988.1316,249,413,053.1716,185,065,118.18
  资产总计30,443,940,874.6629,640,670,093.0228,719,319,567.228,209,443,637.49
流动负债:
  短期借款465,384,988.86645,440,666.651,328,783,908.312,308,058,808.27
  应付票据及应付账款886,386,758.18884,644,797.82801,475,502.33930,521,860.04
        应付账款886,386,758.18884,644,797.82801,475,502.33930,521,860.04
  合同负债174,325,007.4193,284,804.68179,963,929.91129,715,572.1
  应付职工薪酬54,481,594.1752,182,703.7253,146,777.0883,557,507.7
  应交税费65,837,935.1977,040,693.8855,677,541.729,491,548.1
  其他应付款合计54,844,242.0916,202,389.4220,022,719.8418,897,223.58
  一年内到期的非流动负债1,021,265,002.18900,171,062.75781,581,328.21274,438,927.53
  其他流动负债11,302,378.734,923,231.5114,559,045.449,516,040.3
  流动负债合计2,733,827,906.812,673,890,350.433,235,210,752.823,784,197,487.62
非流动负债:
  长期借款3,278,051,257.242,921,134,153.622,632,942,962.281,830,688,787.95
  应付债券4,372,654,410.454,341,279,220.454,309,851,239.784,278,635,022.35
  租赁负债17,286,015.6919,554,033.1520,593,040.0521,955,450.29
  预计负债21,392,410.5912,047,838.6812,518,050.8316,150,363.96
  递延收益143,904,549.85144,319,776.29144,760,934.25145,154,871.75
  递延所得税负债182,233,220.75183,777,972.5181,616,734.45173,781,489.84
  非流动负债合计8,015,521,864.577,622,112,994.697,302,282,961.646,466,365,986.14
  负债合计10,749,349,771.3810,296,003,345.1210,537,493,714.4610,250,563,473.76
所有者权益(或股东权益):
  实收资本(或股本)8,831,762,7288,831,702,7288,831,672,7288,831,529,228
  其他权益工具364,139,939.87364,149,441.29364,154,192364,176,916.23
  资本公积1,126,967,943.091,053,854,821.86980,928,760.67950,177,322.57
  减:库存股689,215,191.24845,579,399.841,748,852,406.891,789,756,980.29
  其他综合收益-75,487,985.32-73,445,404.76-59,018,890.3-39,923,982.7
  专项储备6,898,099.6213,063,106.0113,508,940.8414,305,789.34
  盈余公积600,901,424.23600,901,424.23600,901,424.23600,901,424.23
  未分配利润9,399,444,669.659,325,719,306.759,119,150,084.058,945,561,031.41
  归属于母公司股东权益合计19,565,411,627.919,270,366,023.5418,102,444,832.617,876,970,748.79
  少数股东权益129,179,475.3874,300,724.3679,381,020.1481,909,414.94
  股东权益合计19,694,591,103.2819,344,666,747.918,181,825,852.7417,958,880,163.73
  负债和股东权益合计30,443,940,874.6629,640,670,093.0228,719,319,567.228,209,443,637.49
公告日期2026-10-272026-08-182026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑